Who is sponsoring NCT05759845?

NCT05759845 is sponsored by Dr. Reaz Mahmud.

What drugs are being tested in NCT05759845?

Interventions: Topiramate 25Mg Tab, Amitriptyline 25 Mg Oral Tablet, topiramate 25mg plus amitriptyline 25mg.

What is the status of NCT05759845?

NCT05759845 is currently UNKNOWN.

Last reviewed 2023-03-08 · How we verify

Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis

NCT05759845 PHASE4 UNKNOWN

The goal of this clinical trial is to compare the efficacy and safety of Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis in outddor migraine patients attending headache clinic. The main question it aims to answer is whether there is any difference between the efficacy of Topiramate, Amitriptyline monotherapy and combination therapy in migraine prophylaxis. Participants will take Topiramate, Amitriptyline Monotherapy and Combination Therapy and maintain a headache diary. Researchers will compare Topiramate, Amitriptyline Monotherapy and Combination Therapy groups to see if there is any differences in efficacy and safety.

Details

Lead sponsor	Dr. Reaz Mahmud
Phase	PHASE4
Status	UNKNOWN
Enrolment	150
Start date	Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed May 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Migraine

Interventions

Topiramate 25Mg Tab
Amitriptyline 25 Mg Oral Tablet
topiramate 25mg plus amitriptyline 25mg

Countries

Bangladesh